Long‐term efficacy and safety of CT‐P13, a biosimilar of infliximab, in patients with inflammatory bowel disease: A retrospective multicenter study-Reference-Cited by-同舟云学术

Long‐term efficacy and safety of CT‐P13, a biosimilar of infliximab, in patients with inflammatory bowel disease: A retrospective multicenter study

Published:2019-03-18 Issue:9 Volume:34 Page:1523-1532
ISSN:0815-9319
Container-title:Journal of Gastroenterology and Hepatology
language:en
Short-container-title:Journal of Gastroenterology and Hepatology

Author:

Kim Nam Hee¹,Lee Ji Hyun²,Hong Sung Noh³,Yoon Hyuk⁴,Kang Hyoun Woo⁵,Lee Suck‐Ho⁶,Im Jong Pil⁷,Cha Jae Myung⁸,Eun Chang Soo⁹,Kim Ji Won¹⁰,Choi Chang Hwan¹¹,Park Dong Il¹²

Affiliation:

1. Preventive Healthcare Center, Kangbuk Samsung HospitalSungkyunkwan University School of Medicine Seoul Korea

2. Digestive Endoscopic CenterSeoul Song Do Colorectal Hospital Seoul Korea

3. Department of Medicine, Samsung Medical CenterSungkyunkwan University School of Medicine Seoul Korea

4. Department of Internal MedicineSeoul National University Bundang Hospital Seongnam Korea

5. Department of Internal Medicine, Dongguk University Ilsan HospitalDongguk University College of Medicine Goyang Korea

6. Digestive Endoscopic CenterEsoo Hospital Cheonan‐si Korea

7. Division of Gastroenterology, Department of Internal MedicineSeoul National University Hospital Seoul Korea

8. Department of Internal Medicine, Kyung Hee University Hospital at GangdongKyung Hee University School of Medicine Seoul Korea

9. Department of Internal MedicineHanyang University Guri Hospital Guri Korea

10. Department of Internal Medicine, SMG‐SNU Boramae Medical CenterSNUH College of Medicine Seoul Korea

11. Department of Internal MedicineChung‐Ang University College of Medicine Seoul Korea

12. Division of Gastroenterology, Department of Internal Medicine, Kangbuk Samsung HospitalSungkyunkwan University School of Medicine Seoul Korea

Publisher

Wiley

Subject

Gastroenterology,Hepatology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/jgh.14645

Reference43 articles.

1. Inflammatory bowel disease: clinical aspects and treatments

2. Maintenance infliximab for Crohn's disease: the ACCENT I randomised trial

3. Infliximab for the Treatment of Fistulas in Patients with Crohn's Disease

4. Infliximab for Induction and Maintenance Therapy for Ulcerative Colitis

5. Long-term outcome of treatment with infliximab in 614 patients with Crohn's disease: results from a single-centre cohort

Cited by 21 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Clinical experience of using biosimilars in Crohn’s disease and their effectiveness;Expert Opinion on Biological Therapy;2024-09-13

2. Systematic review: effectiveness and safety of switching between originator infliximab and biosimilar infliximab in patients with inflammatory bowel disease;Expert Opinion on Biological Therapy;2024-07-02

3. Is infliximab therapy currently relevant in patients with inflammatory bowel diseases? (review);Koloproktologia;2024-06-21

4. Long-term effectiveness and safety of infliximab-biosimilar: A multicenter Phoenix retrospective cohort study;PLOS ONE;2023-09-12

5. Clinical Outcomes and Patient Experience of Biosimilar to Biosimilar Infliximab Switching in Patients with Inflammatory Bowel Disease: A Prospective, Single-Centre, Phase IV Interventional Study with a Nested Qualitative Study;GastroHep;2023-08-25